… forecast the company to lose 9 cents a share on revenue of $450 million. One of the key measures of Square’s business health, gross payment volume, also suggested that more merchants are incorporating Square’s little white credit-card scanners into …
Category: Square
BioCardia to Present at the 9TH Annual Biotech Showcase in San Francisco
BioCardia , Inc. [OTC:BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that it is scheduled to present at the 9th Annual Biotech Showcase, being held on January 9-11, 2017 at the Hilton San Francisco Union Square in San Francisco, Dr. Peter Altman, Chief Executive Officer, will provide an update of he Company’s business during the live presentation and will be available for face-to-face conversations with conference attendees. Details for the presentation are as follows: Date: Monday, January 9, 2017 Time: 11:00AM PST.